CLL can be broadly divided into two subgroups based on the presence or absence of somatically mutated immunoglobulin variable heavy chain (IgVH) genes and levels of zeta-chain-associated protein kinase 70 (ZAP70). This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.